Literature DB >> 18418289

HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs.

Maureen Miller1, Yuyan Liao, Meghan Wagner, Caroline Korves.   

Abstract

UNLABELLED: African American women have high rates of most sexually transmitted infections (STIs), including HIV. STIs have been associated with increased HIV transmission risk.
METHODS: Two hundred twenty-eight black women who used drugs completed a structured questionnaire in a central Brooklyn, NY-based research center between March 2003 and August 2005. Women were screened for HIV, herpes simplex virus-2, syphilis, gonorrhea, chlamydia, and trichomoniasis. This analysis determined if STIs cluster within individuals and if clustering and sex practices or partnerships differ by HIV status.
RESULTS: Thirty-eight (17%) women tested HIV seropositive and STI prevalence was herpes simplex virus-2 (79%), trichomoniasis (37%), chlamydia (11%), and gonorrhea (2%). Few women knew themselves to be infected with STIs other than HIV. Excluding HIV, the mean number of STIs per woman was 1.3 (SD 0.7). HIV-infected women were significantly more likely than uninfected women to have multiple positive screens (1.6 vs. 1.2, P = 0.002). Women reported having both lower and higher risk sex partners. HIV-infected women were 2 times more likely than uninfected woman to report current sex work (P = 0.05), the only difference in sex risk. In a linear regression model, crack cocaine use was uniquely associated with multiple positive STI screens, excluding HIV (P = 0.002).
CONCLUSIONS: Several STIs, including HIV, seem to be endemic among black women who use drugs in this community. In addition to the known geographical clustering of HIV and STIs, STIs were also found to cluster at the individual level. Multiply STI infected individuals may unknowingly, but efficiently, contribute to high STI and HIV rates.

Entities:  

Mesh:

Year:  2008        PMID: 18418289     DOI: 10.1097/OLQ.0b013e31816b1fb8

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  16 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Clinical Trial Report: Duration of Metronidazole Therapy in HIV-infected Women with Trichomonas vaginalis: Is More Metronidazole Better?

Authors:  Laura H Bachmann
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

3.  Perception of Eligible Black Men as a Context for HIV Risk Behavior Among Black Women.

Authors:  Danelle Stevens-Watkins; Joi Sheree Knighton; Nathanael Mitchell; Carrie B Oser; Carl Leukefeld
Journal:  J Community Psychol       Date:  2013-08-01

Review 4.  Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis.

Authors:  L M Kucirka; H Sarathy; P Govindan; J H Wolf; T A Ellison; L J Hart; R A Montgomery; R L Ros; D L Segev
Journal:  Am J Transplant       Date:  2011-03-02       Impact factor: 8.086

5.  The incidence of Trichomonas vaginalis infection in women attending nine sexually transmitted diseases clinics in the USA.

Authors:  Maria L Alcaide; Daniel J Feaster; Rui Duan; Stephanie Cohen; Chanelle Diaz; Jose G Castro; Matthew R Golden; Sarah Henn; Grant N Colfax; Lisa R Metsch
Journal:  Sex Transm Infect       Date:  2015-06-12       Impact factor: 3.519

6.  Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users.

Authors:  Maria R Khan; Amanda Berger; Jordana Hemberg; Allison O'Neill; Typhanye Penniman Dyer; Kristina Smyrk
Journal:  AIDS Behav       Date:  2013-03

7.  Trichomonas vaginalis genital infections: progress and challenges.

Authors:  Laura H Bachmann; Marcia M Hobbs; Arlene C Seña; Jack D Sobel; Jane R Schwebke; John N Krieger; R Scott McClelland; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

Review 8.  Trichomoniasis and HIV interactions: a review.

Authors:  Patricia Kissinger; Alys Adamski
Journal:  Sex Transm Infect       Date:  2013-04-20       Impact factor: 3.519

9.  Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009.

Authors:  Dana P Goldman; Timothy Juday; Daniel Seekins; Mark T Linthicum; John A Romley
Journal:  Health Aff (Millwood)       Date:  2014-03       Impact factor: 6.301

Review 10.  A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Authors:  Elissa Meites; Charlotte A Gaydos; Marcia M Hobbs; Patricia Kissinger; Paul Nyirjesy; Jane R Schwebke; W Evan Secor; Jack D Sobel; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.